Key Points Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The ...

However, Trump lacks both the statutory authority and the regulatory mechanisms to force drugmakers to offer their products at “Most Favored Nation” rates in any market, according to Spencer Perlman, ...

White House Press Secretary Karoline Leavitt announced at Thursday's press conference that President Donald Trump had signed ...

Trump signed an Executive Order May 12 directing the administration to take action to bring drug prices charged in the U.S.

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, ...

President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

White House Press Secretary Karoline Leavitt said on Thursday that President Donald Trump is set to send out letters to 17 ...

Trump sent a letter to 17 drug companies demanding a commitment to lower prices in the next 60 days through a series of initiatives.

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

How Lilly could be affected Lilly CEO Dave Ricks addressed the issue of tariffs head-on in his company's first-quarter earnings call on May 1, 2025.